NCT01766089View on ClinicalTrials.gov

Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
PregnancySevere Pre-eclampsia
Interventions
DRUG

Remifentanil

Remifentanil (0.1 µg/kg/min) starting 5 min before induction of anaesthesia and continued until peritoneal closure.

DRUG

Dexmedetomidine

dexmedetomidine (0.4 µg/kg/h) starting 20 before induction of anaesthesia and continued until peritoneal closure

Trial Locations (1)

050

Mansoura University Hospitals, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT01766089 - Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery | Biotech Hunter | Biotech Hunter